论文部分内容阅读
目的:分析50例晚期肺鳞癌患者的临床治疗情况。方法:我院2014年6月至2016年6月收治的50例晚期肺鳞癌患者采取替吉奥联合顺铂的方案进行疾病治疗,对其临床疗效和不良反应进行观察和分析。结果:本组50例患者的疾病控制率为76.0%,治疗期间未见严重的不良反应及死亡情况,其中脱发4例,胃肠道症状6例,骨髓抑制5例。结论:晚期肺鳞癌患者采取替吉奥联合顺铂方案治疗疾病的临床效果显著,值得推广和运用。
Objective: To analyze the clinical treatment of 50 patients with advanced squamous cell carcinoma of the lung. Methods: 50 patients with advanced squamous cell carcinoma admitted to our hospital from June 2014 to June 2016 were enrolled in the study. Their clinical efficacy and adverse reactions were observed and analyzed. Results: The disease control rate was 76.0% in 50 patients. There were no serious adverse reactions and deaths during the treatment, including 4 cases of alopecia, 6 cases of gastrointestinal symptoms and 5 cases of myelosuppression. Conclusion: The clinical effect of taking TIGO combined with cisplatin in the treatment of advanced lung squamous cell carcinoma is significant and worthy of popularization and application.